Brand Institute is the global leader in healthcare related brand name and visual identity development. We partner on approximately 80% of pharmaceutical brand and nonproprietary (INN/USAN) names approved every year, and have extensive experience naming clinical trials, medical devices, diagnostics, digital health products and patient support programs.
Our services include name creation, trademark screening, market research and visual identity. Brand Institute’s subsidiary, Drug Safety Institute (DSI), is led by former regulatory officials from the FDA, EMA and Health Canada.
These industry thought leaders helped shape the global regulatory landscape as it pertains to pharmaceutical name development and now provide our clients with unparalleled guidance in the fields of name strategy, name safety research, labeling/packaging, and risk management.
Jul 23, 2020
Posted by Brand Institute